A molecular genetic study of primary open angle glaucoma
primary open angle glaucoma is one of the commonest causes of blindness in the Western World. Patients with myocillin mediated glaucoma have a worst prognosis. This research will detect those individuals at an early stage and allow better management of their condition. It will also allow early detection of relatives who are also genetically predisposed to glaucoma and need careful clinical followup to prevent permanent visual loss. It will also allow other family members not affected genetically to be discharged from clinical care. This will therefore save the health service valuable resources.
|PI Name||Denniston - A|
|Sponsor||Southampton University Hospitals NHS Trust|
|Proposed End Date||09/08/2019|
|Study Run through CRF?||Yes|
|Target number of patients agreed to recruit||50|
|Recruitment so far||177|